Parenteral Drugs (India) Share Price
₹2.90 0.00 (0.00%)
23 Dec, 2024 07:37
Start SIP in PDPL
Start SIPPerformance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume
Investment Returns
Smart Investing Starts Here Start SIP with Parenteral Drugs (India) for Steady Growth!
Parenteral Drugs (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -0.1
- PEG Ratio
- -0
- Market Cap Cr
- 9
- P/B Ratio
- -0
- Average True Range
- 0.15
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.2
- RSI
- 36.04
- MFI
- 3.73
Parenteral Drugs (India) Financials
Parenteral Drugs (India) Technicals
EMA & SMA
Current Price
₹2.90
0
(0%)
- Bullish Moving Average 0
- Bearish Moving Average 0
- 20 Day
- ₹3.24
- 50 Day
- ₹3.47
- 100 Day
- ₹3.54
- 200 Day
- ₹3.72
Resistance and Support
2.83
- R3 3.17
- R2 3.03
- R1 2.97
- S1 2.77
- S2 2.63
- S3 2.57
Parenteral Drugs (India) Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2022-05-30 | Audited Results & Others | Inter alia, to consider : The shifting of registered office of the Company within local limits of the city. |
2022-02-14 | Quarterly Results | |
2022-02-02 | Others | inter alia, To consider appointment of Independent Director and to consider sale, lease or disposal of the whole or substantially the whole of the undertaking of the Company. |
2021-11-12 | Quarterly Results | |
2021-08-10 | Quarterly Results |
Parenteral Drugs (India) F&O
About Parenteral Drugs (India)
- NSE Symbol
- PDPL
- BSE Symbol
- 524689
- ISIN
- INE904D01019
Similar Stocks to Parenteral Drugs (India)
Parenteral Drugs (India) FAQs
Parenteral Drugs (India) share price is ₹2 As on 23 December, 2024 | 07:23
The Market Cap of Parenteral Drugs (India) is ₹8.6 Cr As on 23 December, 2024 | 07:23
The P/E ratio of Parenteral Drugs (India) is -0.1 As on 23 December, 2024 | 07:23
The PB ratio of Parenteral Drugs (India) is -0 As on 23 December, 2024 | 07:23
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.